[144] PRICE T ROWE GROUP INC SEC Filing
Rhea-AI Filing Summary
Price T Rowe Group insider intends to sell 3,090 common shares acquired through a stock option exercise on 09/22/2025. The sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value reported as $324,466.07 and the company showing 219,715,241 shares outstanding. The filer reports no securities sold in the past three months and indicates payment was made in cash. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- Transparent disclosure of acquisition method (stock option exercise) and broker details
- No prior sales in the past three months reported, simplifying aggregation under Rule 144
Negative
- None.
Insights
TL;DR: Routine insider sale following option exercise; size is immaterial relative to outstanding shares.
The filing shows an insider exercised options and plans to sell 3,090 shares via a broker on NASDAQ for an aggregate of $324,466.07. Relative to the reported 219.7 million shares outstanding, this transaction represents a de minimis fraction of equity, suggesting limited immediate market impact. The notice states no sales in the prior three months and that the consideration was cash, indicating a straightforward liquidity event rather than a complex disposition. No material non-public information is asserted.
TL;DR: Compliance-focused disclosure consistent with Rule 144; no governance red flags in the filing.
The Form 144 provides required broker, acquisition, and payment details: the shares were acquired by option exercise and the sale will be brokered by Morgan Stanley Smith Barney LLC. The filer affirms the absence of undisclosed material adverse information, and nothing in the form indicates late filing, aggregation issues, or prior sales in the three-month window. From a governance perspective, this is a routine disclosure meeting Rule 144 notice requirements.